4
Changes in Ownership
Janux Therapeutics, Inc. Filed Acc 0001864159-26-000002
Chief Business Officer sold 1,879 shares at $13.73 ($25,799)
From the SEC's structured data for this filing
Trades in this filing
Meyer Andrew Hollman · Chief Business Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-02 | Sale : show line 1 in the form | −1,879 | $13.73 | $25,799 | 83,095 | D |
| Open-market sales · 1,879 sh · avg $13.73 · $25,799 | ||||||
Loading xslF345X05/form4-01022026_090112.xml…